StockData
Tyra Biosciences, Inc. logo

Tyra Biosciences, Inc. (TYRA) stock

TYRANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$19.61+0.04 (+0.20%)

Close on Nov 18, 2026Market cap $1.17BP/E –Yield –

Tyra Biosciences revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for Tyra Biosciences

Tyra Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Tyra Biosciences figures

See a number that looks wrong?